Mozart Therapeutics
Regulatory CD8 T cells | Autoimmune and Inflammatory diseases
United States · $80.0M raised
- Website
- mozart-tx.com
- Total Funding
- $80.0M
- Last Round
- $25.0M Extension RoundJun 2023
- Rounds
- 2
About
Clinical-stage biopharmaceutical company developing disease-modifying therapies that restore healthy immune system function to treat autoimmune and inflammatory diseases.
Summary
Mozart Therapeutics is a Biotech company based in United States. It has raised $80.0M in total across 2 rounds, most recently a $25.0M Extension Round round in Jun 2023. Investors include ARCH Venture Partners, Sofinnova Partners and UPMC Enterprises.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company